Vitamin B5 could be the key to treating a rare genetic disease, a study has found.

Published Date: 08 Mar 2023

A study by Concordia undergraduate students suggests that a simple vitamin can cure a rare but life-threatening disease.

Read Full News

Latest News

Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Gen Z Fitness Trend: Are Group Workouts Better?

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

What to Know About the US Outbreak Of Cyclosporiasis

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

Oxford Begins First Human Trial Of Bundibugyo Ebola Vaccine

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate ⁠efforts to combat an outbreak spreading in the...

Two- vs Three-Drug Combo for HIV Infection: No Clear Winner

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir plus lamivudine and those on integrase inhibitor-based three-drug regimens.

Nintedanib Shows No Benefit Over Placebo in Post-COVID ILD

Among patients with post-COVID interstitial lung disease, nintedanib does not provide significant benefit over placebo.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate ⁠efforts to combat an outbreak spreading in the...

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir plus lamivudine and those on integrase inhibitor-based three-drug regimens.

Among patients with post-COVID interstitial lung disease, nintedanib does not provide significant benefit over placebo.

News All Time

Congo Bans Gatherings in Kinshasa and Three Provinces Over Ebola Outbreak

The Democratic Republic of Congo has banned public gatherings in four provinces, including the capital, Kinshasa, as ⁠the country battles a deadly Ebola...

Ebola Outbreak Could Cost Africa Up to $3.6 Billion, UN Says

(Edits headline to spell out 'billion')

Can Early Metformin Treatment Prevent Long COVID Symptoms?

Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed cases, a study finds.

Africa CDC Seeks $18 Million in Urgent Support for Ebola Drug Trials in DRC

The Africa Centres for Disease Control and Prevention on Tuesday called for $18 million in urgent ⁠funding to support trials of experimental Ebola treatments in the...

WHO Issues Clinical Care Advice for Ebola

New recommendations focus on supportive care, shared decision-making, and infection control.

Congo Says Number Of Confirmed Ebola Cases At 1,274, Including 360 Deaths

⁠The Democratic ⁠Republic ⁠of Congo ‌said late on ‌Sunday that ‌confirmed ‌Ebola ⁠cases ‌in ⁠the country ‌had reached 1,274, including ‌360...

Antiretroviral Therapy

Review clinical reference information, guidelines, and medical news on antiretroviral therapy, HIV treatment, and AIDS treatment. Learn about antiretroviral treatment including antiretroviral medications and HIV drugs.

Congo Says Number Of Confirmed Ebola Cases Rises to 1,155

The number of confirmed ⁠Ebola cases in the Democratic Republic ⁠of Congo has increased to ⁠1,155, including ‌304 deaths, government data showed on Thursday.

EU Commission Opens Antitrust Probe Into Sanofi's Flu Vaccine Campaign

The European Commission opened an investigation on ⁠Friday into whether French drugmaker Sanofi breached EU competition ⁠rules in a flu vaccine marketing...

US Military Requires Flu Vaccine for Some After Outbreak in Texas Training Center

The U.S. military has resumed requiring flu vaccines for some service members in an exception to Defense ⁠Secretary Pete Hegseth's guidance declaring the shots voluntary two...

Africa CDC Says Funding Needs for Ebola Response Three Times Higher At $1.4 Billion

Africa's top public health agency said on Thursday that funding needed ⁠to tackle the continent's Ebola outbreak was three times higher than an earlier estimate, and now...

Australia Ramps Up Bird Flu Testing as Second State Reports Case

Australian authorities ramped up surveillance and testing of wildlife and livestock on Wednesday after a second state reported a case ⁠of the highly pathogenic H5N1 bird...

WHO Says Congo's Ebola Outbreak Still Fast-moving and Health Workers Under Threat

The Ebola outbreak in Democratic Republic of Congo is still outpacing response efforts, and frontline health workers there ⁠face very risky conditions, World Health...

Cytokine Scaffold Builds Long-Lived CAR T Cells Against HIV

A new approach aims to use CAR T cells to last longer in the fight against HIV.

UNICEF, Gavi Call to Speed Bundibugyo Ebola Vaccine Access

UNICEF and global vaccine group Gavi said on Wednesday they are seeking information from developers and manufacturers ⁠on plans for a vaccine against the Bundibugyo strain...

Ebola Infects More Than 1,000 in Congo, Spreads to Kill Toddler in New Camp

Ebola has now infected more than 1,000 people in the Democratic Republic of Congo in ⁠an outbreak that has spread to a third displacement camp and killed an 18-month-old...

Recommended News For You

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Implant-based reconstruction linked to increased risk of breast lymphomas

Research uncovers hidden Australian skin cancer epidemic

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Recommended Articles For You

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases? 

How to Manage Dic with the Right Treatment Approach 

Innovative Pathways in Oncology Across Clinical Settings 

Finding Support: Connecting with the Vitiligo Community 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mapping lifelong chronic health risks for childhood cancer survivors

2.

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

3.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

1.

Target-Mediated Drug Disposition in Hematologic Therapeutics

2.

Unlocking the Potential of Polatuzumab for Cancer Treatment

3.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

4.

An Overview Of Leukemia Cutis: What It Is And How To Treat It

5.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot